US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 93.940
  • -1.250-1.31%
Close Feb 14 16:00 ET
  • 93.940
  • 0.0000.00%
Post 17:01 ET
6.00BMarket Cap-87.79P/E (TTM)

About Blueprint Medicines Company

Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Company Profile

SymbolBPMC
Company NameBlueprint Medicines
Listing DateApr 30, 2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees649
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580
Websitehttp://www.blueprintmedicines.com

Company Executives

  • Name
  • Position
  • Salary
  • Kathryn Haviland
  • Director, President and Chief Executive Officer
  • 6.43M
  • Debra Durso-Bumpus
  • Chief People Officer
  • --
  • Tracey L. McCain, Esq.
  • Chief Legal and Compliance Officer
  • --
  • Michael Landsittel, M.B.A.
  • Chief Financial Officer
  • 2.19M
  • Dr. Becker Hewes, M.D.
  • Chief Medical Officer
  • --
  • Dr. Percy H. Carter, M.B.A.,PhD
  • Chief Scientific Officer
  • 2.30M
  • Christina Rossi, M.B.A.
  • Chief Operating Officer
  • 2.81M
  • Dr. Christopher K. Murray, PhD
  • Chief Technical Operations and Quality Officer
  • --
  • Dr. Philina Lee, PhD
  • Chief Commercial Officer
  • --
  • Ariel Hurley
  • Senior Vice President, Finance and Principal Accounting Officer
  • --
  • Dr. Fouad Namouni, M.D.
  • President, Research and Development
  • 2.80M
  • Jeffrey W. Albers, J.D.
  • Chairman of the Board
  • 526.08K
  • Alexis A. Borisy, A.M.
  • Director
  • 397.33K
  • Dr. Nicholas Lydon, F.R.S.,PhD
  • Independent Director
  • 417.33K
  • Daniella Beckman
  • Independent Director
  • 422.33K
  • Habib Joseph Dable
  • Independent Director
  • 412.33K
  • Dr. Mark Alan Goldberg, M.D.
  • Independent Director
  • 419.33K
  • Dr. John Tsai, M.D.
  • Independent Director
  • 769.80K
  • Lonnel Coats
  • Independent Director
  • 419.33K
  • Dr. Lynn Seely,M.D.
  • Lead Independent Director
  • 452.33K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call